https://www.selleckchem.com/products/myk-461.html
Results A total of 1262 patients received the following placebo (n = 459), BRV 50 mg/day (n = 20, BRV 100 mg/day (n = 353), and BRV 200 mg/day (n = 25. Both the incidence (p less then .0001) and prevalence (p less then .0001) of drug-related CNS TEAEs (all with frequency ≥ 5%) changed across time with peak TEAEs in week 1 then significantly reducing over the first 6 weeks for prevalence and the first 3 weeks for incidence. Conclusions Drug-related CNS TEAEs occurred early and substantially habituated over several weeks. TEAEs of ASM
Like
Comment
Share
